Clough Capital Partners L P Humacyte, Inc. Transaction History
Clough Capital Partners L P
- $833 Million
- Q4 2024
A detailed history of Clough Capital Partners L P transactions in Humacyte, Inc. stock. As of the latest transaction made, Clough Capital Partners L P holds 104,400 shares of HUMA stock, worth $369,576. This represents 0.06% of its overall portfolio holdings.
Number of Shares
104,400
Previous 178,768
41.6%
Holding current value
$369,576
Previous $972,000
45.78%
% of portfolio
0.06%
Previous 0.11%
Shares
5 transactions
Others Institutions Holding HUMA
# of Institutions
172Shares Held
41MCall Options Held
553KPut Options Held
942K-
Black Rock Inc. New York, NY7.14MShares$25.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$19.8 Million0.0% of portfolio
-
State Street Corp Boston, MA4.61MShares$16.3 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA2.85MShares$10.1 Million0.11% of portfolio
-
Geode Capital Management, LLC Boston, MA2.14MShares$7.56 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $365M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...